Abstract
AIMS AND METHOD: Response to antidepressants depends on patients' use. Our objective is to take a look over antidepressants use in a real sample. In determining relevant factors, data were gathered from 550 patients, currently taking antidepressants. The questionnaire included two items, patients' perceived difficulty of following treatment and level of acknowledged non-compliance, which may be considered as a way of approximating the patients' real use of treatment. RESULTS: compliance was poor among the less educated, living in rural areas and receiving concomitant treatment. Use perceived as good in 61.5%, better in affective disorder (69.8%). Patients without response present higher incidence of non-compliance (49.1%). It should be mandatory to explore and reinforce a good use of antidepressants in clinical settings, particularly if the indication is not an affective disorder and in case of multiple treatments, rural setting, and lower educational level. If response is inadequate, compliance must be revised specially.
Keywords: Adherence, antidepressant, antidepressant indication, compliance, patients' perception, treatment response, use of treatment, Venlafaxine, hypochondriac depressive symptoms
Current Drug Therapy
Title: Use and Results of Antidepressant Treatment: Patients' Perception
Volume: 6 Issue: 4
Author(s): Maria-Jose Martin-Vazquez, Mauro Garcia-Toro, Francisco Campoamor, Antonio Pareja, Iratxe Aguirre, Joan Salva and Miquel Roca
Affiliation:
Keywords: Adherence, antidepressant, antidepressant indication, compliance, patients' perception, treatment response, use of treatment, Venlafaxine, hypochondriac depressive symptoms
Abstract: AIMS AND METHOD: Response to antidepressants depends on patients' use. Our objective is to take a look over antidepressants use in a real sample. In determining relevant factors, data were gathered from 550 patients, currently taking antidepressants. The questionnaire included two items, patients' perceived difficulty of following treatment and level of acknowledged non-compliance, which may be considered as a way of approximating the patients' real use of treatment. RESULTS: compliance was poor among the less educated, living in rural areas and receiving concomitant treatment. Use perceived as good in 61.5%, better in affective disorder (69.8%). Patients without response present higher incidence of non-compliance (49.1%). It should be mandatory to explore and reinforce a good use of antidepressants in clinical settings, particularly if the indication is not an affective disorder and in case of multiple treatments, rural setting, and lower educational level. If response is inadequate, compliance must be revised specially.
Export Options
About this article
Cite this article as:
Martin-Vazquez Maria-Jose, Garcia-Toro Mauro, Campoamor Francisco, Pareja Antonio, Aguirre Iratxe, Salva Joan and Roca Miquel, Use and Results of Antidepressant Treatment: Patients' Perception, Current Drug Therapy 2011; 6 (4) . https://dx.doi.org/10.2174/157488511798109619
DOI https://dx.doi.org/10.2174/157488511798109619 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease
Current Psychopharmacology Clinical Perspectives on Antidepressant Drug Development: A Critical Discussion
Current Pharmaceutical Design Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Do Adenosine Receptors Offer New Therapeutic Options for Diabetic Nephropathy?
Current Vascular Pharmacology Renal Development: A Complex Process Dependent on Inductive Interaction
Current Pediatric Reviews Impact of Fenofibrate on Type 2 Diabetes Patients with Features of the Metabolic Syndrome: Subgroup Analysis From FIELD
Current Cardiology Reviews Contemporary Pharmacologic Management of Heart Failure with Reduced Ejection Fraction: A Review
Current Cardiology Reviews Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
Current Vascular Pharmacology Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Current Pharmaceutical Design Stage A: Can Heart Failure Be Prevented?
Current Cardiology Reviews Linagliptin: A Novel Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor for Treatment of Type II Diabetes Mellitus
Current Diabetes Reviews Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Current Drug Safety Editorial (Hot Topic: Coming Back to Nature: Plants as a Vital Source of Pharmaceutically Important Metabolites – Part II A)
Current Medicinal Chemistry Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus
Current Topics in Medicinal Chemistry Recent Advances in Polymer-based Wound Dressings for the Treatment of Diabetic Foot Ulcer: An Overview of State-of-the-art
Current Drug Targets Drug Withdrawal and Hyperphagia: Lessons from Tobacco and Other Drugs
Current Pharmaceutical Design Retinol-Binding Protein 4 and New Adipocytokines in Nonalcoholic Fatty Liver Disease
Current Pharmaceutical Design EHDA Spraying: A Multi-Material Nano-Engineering Route
Current Pharmaceutical Design EBI2, GPR18, and GPR17 – Three Structurally Related but Biologically Distinct 7TM Receptors
Current Topics in Medicinal Chemistry Neonatal Fc Receptor and its Role in the Absorption, Distribution, Metabolism and Excretion of Immunoglobulin G-Based Biotherapeutics
Current Drug Metabolism